AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract HHSO100201100004CCHEMO-SERO-THERAPEUTIC RESEAECH INSTITUTE, THE
Overview
Award facts
- Net obligations
- $9.77M
- $9,772,495of $33.93M potential value
- Period of performance
- Sep 25, 2018 to Sep 25, 2018
- Ended
- Modifications
- 10
- Latest action Sep 25, 2018
- Contract type
- Definitive contract
- PIID HHSO100201100004C
Description of requirement
KAKETSUKEN BASE YEAR FUNDING FOR THE ADVANCED DEVELOPMENT OF A LIVE ATTENUATED SMALLPOX VACCINE CAN1992002
Dates and value
- Award date
- Signed on Dec 17, 2010
- Potential end of performance
- Sep 24, 2018
- Current value
- $9,772,495Base and exercised options
- Potential value (if all options are exercised)
- $33,926,853
Obligations by fiscal year of action
- FY2018: -$39,497 (de-obligation)
- FY2011: $9,811,992
Total across 2 fiscal years: $9,772,495
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 25, 2018. View on USAspending · Recipient on SAM.gov
Recipient
LocationKUMAMOTO, JPN
UEIFEV7JWPM7J69
CAGE codeSHT60
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org
Parent companyCHEMO-SERO-THERAPEUTIC RESEAECH INSTITUTE, THE
Business types and certifications
Foreign-ownedNonprofit organizationInternational organization
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- 075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Japan
Classification and competition
Classification
- Product or service (PSC)
- C118RESEARCH AND DEVELOPMENT FACILITIES (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 10
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Development of an alternative live attenuated vaccinia vaccine (LC16M8) for the prevention of smallp
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Dec 17, 2010Base obligation at award: $9,811,992
- Latest action
- Sep 25, 2018 — Other administrative actionModification 11; obligation change -$39,497; administrative: no change in scope or value
- Latest substantive action
- Sep 13, 2011 — Option exercisedModification 3
- Actions by type
- Base award1
- Other administrative action9
- Option exercised1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$39,497
- Latest action: change in base and all options
- -$39,497
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- JapanJPN
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 11
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2010/2013-0140-000
- Object classes
- 25.3: Other goods and services from Federal sources